Generic velpatasvir plus sofosbuvir for hepatitis C virus infection in patients with or without human immunodeficiency virus coinfection-Reference-Cited by-同舟云学术

Generic velpatasvir plus sofosbuvir for hepatitis C virus infection in patients with or without human immunodeficiency virus coinfection

Published:2018-04-17 Issue:12 Volume:47 Page:1690-1698
ISSN:0269-2813
Container-title:Alimentary Pharmacology & Therapeutics
language:en
Short-container-title:Aliment Pharmacol Ther

Author:

Liu C.-H.¹²³^ORCID,Sun H.-Y.¹,Liu C.-J.¹²⁴^ORCID,Sheng W.-H.¹,Hsieh S.-M.¹,Lo Y.-C.⁵,Liu W.-C.¹,Su T.-H.¹²,Yang H.-C.¹²⁶,Hong C.-M.⁷,Tseng T.-C.¹²,Chen P.-J.¹²⁴,Chen D.-S.¹²⁸,Hung C.-C.¹⁹¹⁰^ORCID,Kao J.-H.¹²⁴^ORCID

Affiliation:

1. Department of Internal Medicine; National Taiwan University Hospital; Taipei Taiwan

2. Hepatitis Research Center; National Taiwan University Hospital; Taipei Taiwan

3. Department of Internal Medicine; National Taiwan University Hospital; Douliou Taiwan

4. Graduate Institute of Clinical Medicine; National Taiwan University College of Medicine; Taipei Taiwan

5. Centers for Disease Control; Taipei Taiwan

6. Department of Microbiology; National Taiwan University College of Medicine; Taipei Taiwan

7. Department of Traumatology; National Taiwan University Hospital; Taipei Taiwan

8. Genomics Research, Center; Academia Sinica; Taipei Taiwan

9. Department of Parasitology; National Taiwan University College of Medicine; Taipei Taiwan

10. Department of Medical Research; China Medical University Hospital; Taichung Taiwan

Funder

Ministry of Science and Technology, Taiwan

Publisher

Wiley

Subject

Pharmacology (medical),Gastroenterology,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/apt.14647/fullpdf

Reference43 articles.

1. The natural history of hepatitis C virus infection: host, viral, and environmental factors;Thomas;JAMA,2000

2. Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study;Polaris Observatory HCV Collaborators;Lancet Gastroenterol Hepatol,2017

3. Prevalence and burden of HCV co-infection in people living with HIV: a global systematic review and meta-analysis;Platt;Lancet Infect Dis,2016

4. Quantitative evaluation of hepatitis C virus RNA in patients with concurrent human immunodeficiency virus infections;Sherman;J Clin Microbiol,1993

5. HIV, age, and the severity of hepatitis C virus-related liver disease: a cohort study;Kirk;Ann Intern Med,2013

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cutting-edge pharmacotherapy for hepatitis C virus infection: a comprehensive review;Expert Opinion on Pharmacotherapy;2024-08-12

2. SASLT guidelines: Update in treatment of hepatitis C virus infection, 2024;Saudi Journal of Gastroenterology;2024-01

3. Safety considerations in the management of hepatitis C and HIV co-infection;Expert Opinion on Drug Safety;2023-04-27

4. Collaborative Referral Model to Achieve Hepatitis C Micro-Elimination in Methadone Maintenance Treatment Patients during the COVID-19 Pandemic;Viruses;2022-07-27

5. Hepatitis C Virus Reinfection in People With HIV in Taiwan After Achieving Sustained Virologic Response With Antiviral Treatment: The RECUR Study;Open Forum Infectious Diseases;2022-07-22